Lataa...
Commentary: Bone morphogenetic protein's contribution to pulmonary artery hypertension: Should this raise concern for patients undergoing spinal fusions with bone morphogenetic protein?
BACKGROUND: Congenital pulmonary artery hypertension (PAH) has been clinically correlated in 70–80% of cases with mutations at the bone morphogenetic protein receptor 2 (BMPR2) genetic site. However, there is also clinical and basic science/laboratory literature indicating a dose–response relationsh...
Tallennettuna:
| Julkaisussa: | Surg Neurol Int |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Medknow Publications & Media Pvt Ltd
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4287904/ https://ncbi.nlm.nih.gov/pubmed/25593780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2152-7806.148050 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|